No
Fluocinolone Acetonide
Psoriasis
The mechanism of anti-inflammatory activity of the topical corticosteroids is unclear. Various laboratory methods, including vasoconstrictor assays, are used to compare and predict potencies and/or clinical efficacies of the topical corticosteroids. There is some evidence to suggest that a recognizable correlation exists between vasoconstrictor potency and therapeutic efficacy in man.
Fluocinolone Acetonide
Burning , Hypertrichosis , Maceration of the skin , Itching , Acneiform eruptions , Secondary infection , Irritation , Hypopigmentation , Skin atrophy , Dryness ,Perioral dermatitis , Striae Folliculitis , Allergic contact dermatitis , Miliaria
Ask your physician or pharmacist for any drug interactions .
Cream/Oint/Lotion : Steroid responsive skin conditions . Gel : Seborrhoea , seborrhoeic dermatitis and psoriasis of the scalp . Inflammatory dermatoses .
It is contraindicated in those patients with a history of hypersensitivity to any of the components of the preparation.
Children may absorb proportionally larger amounts of topical corticosteroids and thus be more susceptible to systemic toxicity .If irritation develops, topical corticosteroids should be discontinued and appropriate therapy instituted.
In the presence of dermatological infections, the use of an appropriate antifungal or antibacterial agent should be instituted. If a favorable response does not occur promptly, the corticosteroid should be discontinued until the infection has been adequately controlled.
This medication is to be used as directed by the physician. It is for external use only. Avoid contact with the eyes .
Patients should be advised not to use this medication for any disorder other than that for which it was prescribed.
Always consult your physician before using any medicine.
Store this medicine at room temperature, away from direct light and heat.